These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18297448)

  • 21. Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy.
    Young JL; Liss MA; Szabo RJ
    Urology; 2009 Aug; 74(2):332-8. PubMed ID: 19464041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic prophylaxis for transrectal prostate biopsy: a prospective randomized study of tosufloxacin versus levofloxacin.
    Yamamoto S; Ishitoya S; Segawa T; Kamoto T; Okumura K; Ogawa O
    Int J Urol; 2008 Jul; 15(7):604-6. PubMed ID: 18462354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of antibiotic susceptibility of Escherichia coli between community-acquired and post-prostate biopsy acute bacterial prostatitis.
    Park MG; Cho MC; Cho SY; Lee JW
    Arch Esp Urol; 2019 Dec; 72(10):1018-1025. PubMed ID: 31823850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bisacodyl rectal preparation can decrease infectious complications of transrectal ultrasound-guided prostate biopsy.
    Jeon SS; Woo SH; Hyun JH; Choi HY; Chai SE
    Urology; 2003 Sep; 62(3):461-6. PubMed ID: 12946747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occurrence of infection following prostate biopsy procedures in Japan: Japanese Research Group for Urinary Tract Infection (JRGU) - a multi-center retrospective study.
    Togo Y; Kubo T; Taoka R; Hiyama Y; Uehara T; Hashimoto J; Kurimura Y; Takahashi S; Tsukamoto T; Miyazaki J; Nishiyama H; Kira S; Kiyota H; Yazawa S; Niwa N; Hongo H; Oya M; Kato T; Yasuda M; Deguchi T; Ishikawa K; Hoshinaga K; Matsumoto M; Shigemura K; Tanaka K; Arakawa S; Fujisawa M; Wada K; Uehara S; Watanabe T; Kumon H; Kobayashi K; Matsubara A; Matsumoto M; Sho T; Hamasuna R; Matsumoto T; Hayami H; Nakagawa M; Yamamoto S
    J Infect Chemother; 2014 Apr; 20(4):232-7. PubMed ID: 24594451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effectiveness of single-dose fosfomycin as antimicrobial prophylaxis for patients undergoing transrectal ultrasound-guided biopsy of the prostate.
    Ongün S; Aslan G; Avkan-Oguz V
    Urol Int; 2012; 89(4):439-44. PubMed ID: 23006631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for acute prostatitis after transrectal biopsy of the prostate.
    Kim SJ; Kim SI; Ahn HS; Choi JB; Kim YS; Kim SJ
    Korean J Urol; 2010 Jun; 51(6):426-30. PubMed ID: 20577611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should we review our prophylaxis approach for increased antibiotic resistance in transrectal prostate biopsy?
    Altunsoy A; Coşer Ş; Kemirtlek N; Aykanat IC; Balci M; Bodur H; Tuncel A
    J Infect Dev Ctries; 2024 Apr; 18(4):595-599. PubMed ID: 38728642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Blindness after prostate biopsy].
    Heinzelbecker J; von Zastrow C; Alken P
    Urologe A; 2009 Feb; 48(2):175-6. PubMed ID: 19037622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of levofloxacin in the antibiotic prophylaxis for diagnostic procedures in urology].
    Trinchieri A; Mangiarotti B; Lizzano R
    Arch Ital Urol Androl; 2002 Mar; 74(1):33-9. PubMed ID: 12053449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of outpatient parenteral antimicrobial therapy for transrectal ultrasound-guided prostate biopsy prophylaxis in the setting of community-associated multidrug-resistant Escherichia coli rectal colonization.
    Shakil J; Piracha N; Prasad N; Kopacz J; Tarasuk A; Farrell R; Urban C; Mariano N; Wang G; Segal-Maurer S
    Urology; 2014 Apr; 83(4):710-3. PubMed ID: 24680441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Empirical management of urinary tract infections complicating transrectal ultrasound guided prostate biopsy.
    Tal R; Livne PM; Lask DM; Baniel J
    J Urol; 2003 May; 169(5):1762-5. PubMed ID: 12686828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk.
    Griffith BC; Morey AF; Ali-Khan MM; Canby-Hagino E; Foley JP; Rozanski TA
    J Urol; 2002 Sep; 168(3):1021-3. PubMed ID: 12187213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ecology and fluoroquinolon resistance profiles in febrile urinary tract infections (FUTI) after prostate needle biopsy: A retrospective study in 466 biopsies].
    Duboureau H; Achkar K; Stephan R; Schmit JL; Saint F
    Prog Urol; 2017 May; 27(6):345-350. PubMed ID: 28478906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluoroquinolone-based antimicrobial prophylaxis in patients undergoing transrectal ultrasound-guided prostate biopsy.
    Sieczkowski M; Gibas A; Bronk M; Matuszewski M
    Eur J Clin Microbiol Infect Dis; 2015 Sep; 34(9):1815-21. PubMed ID: 26048634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of urinary tract infection following transrectal ultrasound guided prostate biopsy at a tertiary-care medical center in Lebanon.
    Otrock ZK; Oghlakian GO; Salamoun MM; Haddad M; Bizri AR
    Infect Control Hosp Epidemiol; 2004 Oct; 25(10):873-7. PubMed ID: 15518032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time of administration of a single dose of oral levofloxacin and its effect in infectious complications from transrectal prostate biopsy.
    Argyropoulos AN; Doumas K; Farmakis A; Liakatas I; Gkialas I; Lykourinas M
    Int Urol Nephrol; 2007; 39(3):897-903. PubMed ID: 17203352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of drug susceptibility between Escherichia coli detected in stool cultures of patients undergoing transrectal prostate needle biopsy and Escherichia coli in hospital-wide urine antibiograms.
    Etani T; Mogami T; Yamaguchi S; Takeda T; Sugino T; Shimizu N; Noda Y; Nagai T; Nozaki S; Iida K; Naiki T; Ando R; Kawai N; Yasui T
    J Infect Chemother; 2022 Feb; 28(2):343-346. PubMed ID: 34750049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Epidemiology and treatment of acute prostatitis after prostatic biopsy].
    Stoica G; Cariou G; Colau A; Cortesse A; Hoffmann P; Schaetz A; Sellam R
    Prog Urol; 2007 Sep; 17(5):960-3. PubMed ID: 17969797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microbiological characteristics of acute prostatitis after transrectal prostate biopsy.
    Bang JH; Choe HS; Lee DS; Lee SJ; Cho YH
    Korean J Urol; 2013 Feb; 54(2):117-22. PubMed ID: 23550205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.